Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Stock-based Compensation Expense

The Company recorded stock-based compensation expense in the following expense categories in its accompanying condensed consolidated statements of operations and comprehensive loss:

	Three Months Ended June 30,				Six Months Ended June 30,
(in thousands)	2023		2022		2023		2022
Research and development	$	63	$	6	$	112	$	12
Sales and marketing		273		5		446		9
Cost of sales		31		3		54		5
General and administrative		129		12		251		26
Total stock-based compensation	$	496	$	26	$	863	$	52

Schedule of Stock Option Activity

The following table summarizes stock option activity for the Plans for the six months ended June 30, 2023:

	Number of shares			Weighted average exercise price per share		Weighted average remaining contractual term (years)		Aggregate intrinsic value (in 000's)
Outstanding at December 31, 2022		4,269,402		$	1.08		6.07	$	38,929
Granted		617,009		$	9.18
Exercised		(151,338	)	$	0.62
Cancelled		(86,667	)	$	1.84
Outstanding at June 30, 2023		4,648,406		$	2.16		5.93	$	76,195
Exercisable at June 30, 2023		2,746,023		$	0.67		3.96	$	49,087
Vested and expected to vest at June 30, 2023		4,649,864		$	2.16		5.93

Schedule of Fair Value of Each Option Estimated Using Weighted Average Assumptions

The fair value of each option was estimated on the date of grant using the weighted average assumptions in the table below:

	June 30, 2023			June 30, 2022
Expected volatility		69.1	%		54.6	%
Risk-free interest rate		3.8	%		3.1	%
Expected term (in years)		6.0			7.8
Expected dividend yield		—	%		—	%